Newborn Screening Latest Update: June 2020 Main Guideline CLASP Guidelines Handouts for Patient Families Argininemia Biotinidase Deficiency: English | Spanish Carrier Identification Carnitine Uptake Deficiency Congenital Adrenal Hyperplasia: English | Spanish Congenital Hypothyroidism: English | Spanish FSA Sickle Beta Plus Thalassemia Glutaric Acidemia, Type II Galactosemia: English | Spanish Hemoglobin SC Disease Homocystinuria/Hypermethioninemia Medium Chain Acyl CoA Dehydrogenase Deficiency Methylmalonic Acidemia and Propionic Acidemia Organic Acid Disorder Amino Acid Disorder (OTC/CPS) Phenylketonuria/Hyperphenylalaninemia Possible Thalassemia Presumed Sickle Cell Disease Tyrosinemia Very Long Chain Acyl-CoA Dehydrogenase Deficiency X-Linked Adrenoleukodystrophy Handouts for Clinicians Communicating Positive Newborn Screen to Families Heel-Stick Specimens for PCPs These guidelines are intended solely for the use of healthcare professionals who are licensed to practice medicine. This material is not intended to replace professional medical judgment, prescribing information or consultation with a medical professional. Any health care provider using this material acknowledges full responsibility for the medical care and treatment of patients. All health care providers are solely responsible for confirming the accuracy, timeliness, completeness, appropriateness and helpfulness of this material and making all medical, diagnostic or prescription decisions. For questions about the guidelines, contact Michele Krivickas via email or at 860.837.6746. Learn more about our Co-Management program >
